Analyst Ratings for Jazz Pharmaceuticals PLC (JAZZ)

Updated: 2017-07-27

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received a consensus rating of Buy from Wall Street analysts. Last month, JAZZ received an average rating of Buy.

A buy rating was issued by 15 analysts, 0 gave an overweight rating, 3 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for JAZZ. The maximum price target given was 210, implying potential capital gains of 32.38 percent. The most pessimistic analyst gave a price target of 144, implying potential capital losses of -9.23 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. That number becomes -4.87 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.05 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -2.47 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of JAZZ's earnings is estimated by analysts to be 9.61 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. JAZZ has a PEG ratio of 2.53.

In the trailing 52-weeks, JAZZ hit 163.75 at the highest peak, while it's lowest trading point was 95.80. The current market price is above the trailing year's low by 65.59 percent, and below the high by 3.12 percent. JAZZ has a P/E ratio of 24.29. Investors typically compare the P/E ratio to a company's peers in the industry. The JAZZ value stock report compares JAZZ to some of its peers using value stock charts. The market cap of JAZZ is $9.71 billion. JAZZ's next earnings release will be on 0000-00-00, which is days away.